Importantly, low TSPAN6 expression was correlated with an EMT signature and poor survival of human patients with non-small cell lung and pancreatic cancers, indicating that TSPAN6 functions as a tumor suppressor in human epithelial cancers. Here, TSPAN6 is linked to neoplasm.